Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats
- PMID: 7514774
- DOI: 10.1016/0304-3940(94)90854-0
Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats
Abstract
The purpose of the present study was to evaluate stroke-prone spontaneously hypertensive rats (SHRSP) neurochemically by determining the cerebrospinal fluid (CSF) levels of acetylcholine (ACh), norepinephrine (NE) and serotonin (5-HT) as an index of central neuronal activity. The CSF ACh levels of 15- to 20-week-old SHRSP were significantly lower than those of age-matched Wistar Kyoto rats (WKY) both under the urethane/alpha-chloralose anesthesia and in freely moving conditions. The difference in the CSF ACh levels between SHRSP and WKY was more marked at 30-40 weeks. Sustained changes were not observed in the CSF NE and 5-HT levels. Thus, the progressive dysfunction in the central cholinergic system may characterize the pathophysiological state of this animal model with cerebral lesions caused by continuous high blood pressure.
Similar articles
-
Simultaneous high-performance liquid chromatographic determination of norepinephrine, serotonin, acetylcholine and their metabolites in the cerebrospinal fluid of anaesthetized normotensive rats.J Chromatogr. 1990 Mar 16;526(1):1-10. doi: 10.1016/s0378-4347(00)82478-0. J Chromatogr. 1990. PMID: 1692842
-
Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats.Stroke. 1996 Mar;27(3):520-5; discussion 525-6. doi: 10.1161/01.str.27.3.520. Stroke. 1996. PMID: 8610323
-
Variation of monoamines and their metabolite contents in the cerebrospinal fluid of conscious rats.Jpn J Pharmacol. 1998 Oct;78(2):237-40. doi: 10.1254/jjp.78.237. Jpn J Pharmacol. 1998. PMID: 9829629
-
[Central hypotensive effect involving neurotransmitters of long-term administration of taurine to stroke-prone spontaneously hypertensive rat].Masui. 2007 Feb;56(2):139-47. Masui. 2007. PMID: 17315726 Japanese.
-
A critical appraisal of CSF monoamine metabolite studies in schizophrenia.Ann N Y Acad Sci. 1988;537:309-23. doi: 10.1111/j.1749-6632.1988.tb42115.x. Ann N Y Acad Sci. 1988. PMID: 2462396 Review. No abstract available.
Cited by
-
Cholinesterase inhibitors and vascular dementia: another string to their bow?CNS Drugs. 2004;18(2):79-92. doi: 10.2165/00023210-200418020-00002. CNS Drugs. 2004. PMID: 14728055 Review.
-
Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit.Vasc Health Risk Manag. 2019 Aug 7;15:259-281. doi: 10.2147/VHRM.S190470. eCollection 2019. Vasc Health Risk Manag. 2019. PMID: 31496716 Free PMC article. Review.
-
Clinical pharmacokinetics of galantamine.Clin Pharmacokinet. 2003;42(15):1383-92. doi: 10.2165/00003088-200342150-00005. Clin Pharmacokinet. 2003. PMID: 14674789 Review.
-
Management of mixed dementia.Drugs Aging. 2010 Sep 1;27(9):715-28. doi: 10.2165/11538250-000000000-00000. Drugs Aging. 2010. PMID: 20809662 Review.
-
Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.Neurotox Res. 2003;5(1-2):1-26. doi: 10.1007/BF03033369. Neurotox Res. 2003. PMID: 12832221 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources